期刊文献+

Effect of depot medroxyprogesterone acetate(DMPA) on bone mineral density(BMD) and evaluating changes in BMD after discontinuation of DMPA in adolescent women

Effect of depot medroxyprogesterone acetate(DMPA) on bone mineral density(BMD) and evaluating changes in BMD after discontinuation of DMPA in adolescent women
原文传递
导出
摘要 Objective To compare bone mineral density (BMD) between users of intramuscular depot medroxyprogesterone acetate (DMPA) and nonhormonal subjects and evaluated the changes in BMD after discontinuation of DMPA.Methods The study included 102 women aged 16-18 years using DMPA for 24 months and 97 same-age nonusers. BMD of the lumbar spine and femoral neck were measured using dual-energy X-ray absorptiometry. The mean BMD values were compared between DMPA users (DMPA group) and nonusers (control group) and the changes of BMD during 36 months after discontinuation of DMPA were observed.Results Mean BMD at the spine and femoral neck did not differ significantly between DMPA group and control group over 12 months, but the BMD values at both anatomical sites were significantly lower in DMPA group than in control group after 24 months treatment. After DMPA discontinuation, the mean BMD values in DMPA users increased substantially. At 24 months after DMPA discontinuation, there were no significant differences between DMPA group and control group. But the values of the lumbar spine and femoral neck BMD in DMPA group were still 1.70% and 1.87%, respectively, below nonusers at 36 months after DMPA discontinuation.Conclusion The use of DMPA for short-term ( ≤12 months) had no significant effects on BMD at spine and femoral neck, but long-term exposure to DMPA had significant loss in BMD in adolescents. Bone loss occurring with DMPA use is reversible after DMPA discontinuation. Objective To compare bone mineral density (BMD) between users of intramuscular depot medroxyprogesterone acetate (DMPA) and nonhormonal subjects and evaluated the changes in BMD after discontinuation of DMPA.Methods The study included 102 women aged 16-18 years using DMPA for 24 months and 97 same-age nonusers. BMD of the lumbar spine and femoral neck were measured using dual-energy X-ray absorptiometry. The mean BMD values were compared between DMPA users (DMPA group) and nonusers (control group) and the changes of BMD during 36 months after discontinuation of DMPA were observed.Results Mean BMD at the spine and femoral neck did not differ significantly between DMPA group and control group over 12 months, but the BMD values at both anatomical sites were significantly lower in DMPA group than in control group after 24 months treatment. After DMPA discontinuation, the mean BMD values in DMPA users increased substantially. At 24 months after DMPA discontinuation, there were no significant differences between DMPA group and control group. But the values of the lumbar spine and femoral neck BMD in DMPA group were still 1.70% and 1.87%, respectively, below nonusers at 36 months after DMPA discontinuation.Conclusion The use of DMPA for short-term ( ≤12 months) had no significant effects on BMD at spine and femoral neck, but long-term exposure to DMPA had significant loss in BMD in adolescents. Bone loss occurring with DMPA use is reversible after DMPA discontinuation.
出处 《Journal of Reproduction and Contraception》 CAS CSCD 2015年第3期151-159,共9页 生殖与避孕(英文版)
基金 supported by a grant from the Research Foundation of the Shandong Provincial Population and Committee of Family Planning,Jinan,Shandong,China(No.2012017)
关键词 depot medroxyprogesterone acetate (DMPA) bone mineral density (BMD) CONTRACEPTION adolescents depot medroxyprogesterone acetate (DMPA) bone mineral density (BMD) contraception adolescents
  • 相关文献

参考文献1

二级参考文献10

  • 1Beksinska ME,,Kleinschmidt I,Smit JA, et al.Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception[].Contraception.2007
  • 2Clark MK,Sowers MF,Levy B, et al.Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate[].Fertility and Sterility.2006
  • 3Tang OS,Tang G,Yip PSF, et al.Further evaluation on long-term depot-medroxyprogesterone acetate use and bone mineral density: a longitudinal cohort study[].Contraception.2000
  • 4Department of Reproductive Health and Research.WHO statement on hormonal contraception and bone health[].Contraception.2006
  • 5Dempster DW,Bolognese MA.The evolution of a once-a-month oral therapyfor postmenopausal osteoporosis[].Journal of Clinical Densitometry.2006
  • 6Ortiz,A,Hiroi,M,Stanczyk,FZ,Goebelsmann,U,Jr,Mishell,DR.Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of Depo-MPA[].The Journal of Clinical Endocrinology.1977
  • 7Miller KK,Klibanski A.Clinical review 106: Amenorrheic bone loss[].The Journal of Clinical Endocrinology.1999
  • 8Clark,MK,Sowers,M,Levy,BT,Tenhundfeld,P.Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception[].Fertility and Sterility.2001
  • 9L&#xfa,cia Costa Paiva Aar&#xe,o Mendes Pinto-Neto and Anibal Faundes &#x00.Bone density among long-term users of medroxyprogesterone acetate as a contraceptive[].Contraception.1998
  • 10P. Wanichsetakul A. Kamudhamas P. Watanaruangkovit Y. Siripakarn and P. Visutakul.Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception[].Contraception.2002

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部